Toggle light / dark theme

Get the latest international news and world events from around the world.

Log in for authorized contributors

Diego Zarco develops biostasis in Mexico

Cryonics and biostasis have been little known and even less practiced in South America. Diego Zarco is working to change that in Mexico. Diego started Criogenia Avanzada in Mexico City and has been developing and funding the organization, preparing to offer SST (standby, stabilization, and transport) services with storage to be done outside the country.

In this discussion, Max More asks Diego how he become interested in cryonics, what his organization does, where Criogenia Avanzada is located in the city and how it will reach patients quickly, and how his experience in the music industry prepared him for the difficult work of making biostasis work in practice.

Google Warns Quantum Computers Could Break Bitcoin and Ethereum Encryption in 9 Minutes — Are Your BTC and ETH at Risk?

In short: The “lock” on the vault hasn’t been broken yet, but Google just published the blueprint for the bolt cutters, and they are much smaller than we imagined.


Google’s latest research warns quantum computers could break Bitcoin and Ethereum encryption faster than expected.

The Future of Transplants: Stopping Rejection Before It Starts — Dr. Janine Gaiha-Rohrbach — Biogen

Dr. Janine Gaiha-Rohrbach, Ph.D. — Head of Global Medical Immunology, Biogen.


Preventing transplant loss doesn’t just save organs—it could eliminate hospitalizations, reduce lifelong medications, and transform millions of lives.

Dr. Janine Gaiha-Rohrbach, Ph.D. is a globally recognized leader in immunology and medical strategy, currently serving as Head of Global Medical Immunology at Biogen (https://www.biogen.com/).

With a PhD in Immunology and Virology from the University Hospital of Berne and extensive postdoctoral research at the Ragon Institute of Mass General Brigham, MIT, and Harvard, Dr. Gaiha-Rohrbach has dedicated her career to translating complex scientific advances into high-impact patient care.

Throughout her career, Dr. Gaiha-Rohrbach has driven innovation across diverse therapeutic areas, including HIV, hepatitis, NASH, and specialized immunology, leading multiple new product launches and shaping global strategies to expand patient access.

Scientists Discover How to Stop Vision Loss Before It Starts

Scientists have identified molecules that can protect the eye’s cone cells from degeneration, a major cause of vision loss. The discovery points to new drug targets—and even uncovers compounds that may be harmful.

Researchers led by Botond Roska at the Institute of Molecular and Clinical Ophthalmology Basel (IOB), along with an international team, have uncovered genetic pathways and chemical compounds that can help protect cone photoreceptors. These cells are damaged in diseases such as age-related macular degeneration, a leading cause of vision loss.

Why cone cells matter for sight.

/* */